Garry W. Rogerson Elected Chairman of the Board of Varian, Inc.
Varian, Inc. reported that its Board of Directors has elected Garry W. Rogerson, the company's President and Chief Executive Officer, as Chairman of the Board. He replaces Allen J. Lauer, who retired from the Board upon expiration of his director term at the annual meeting of stockholders held on February 5, 2009. Rogerson will continue as the company's Chief Executive Officer.
Rogerson joined Varian Associates, Inc. (Varian, Inc.'s predecessor company) in 1979, and held numerous management positions before being appointed chief executive officer in 2004. He has served as the company's president since 2002, and served as chief operating officer from 2002 to 2004, as senior vice president of its scientific instruments business from 2001 to 2002, and as vice president of its analytical instruments business from 1999 to 2001. Rogerson has been a director of the Company since 2003. He is also the non-executive Chairman of the Board of Coherent, Inc. Rogerson earned his Ph.D. in biochemistry from the University of Kent at Canterbury, England.
Most read news
Other news from the department people
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Major advances made in predicting crystal structures - Findings of international test have implications for pharmaceutical development
Frost: Strategic Analysis of the Opportunities for the Pharmaceutical and Biotechnology Industry in the 'New' EU Countries - Pharmaceutical and Biotechnology Industry in the 'New' EU Countries Presents Considerable Potential, Parallel Imports Remain a Challenge
Philips and Concateno Announce Revolutionary Drugs-of-Abuse Testing System
ESA Expands European Customer Service
BEAM | FT-NIR-Prozessspektrometer | Bruker
PerkinElmer and IDBS Announce Software Collaboration to Improve High Content Screening Outcomes for Drug Discovery Research
LUM moves location of US subsidiary LUM Corp. to Austin, TX
The 2011 Körber Prize goes to Stefan Hell - With a groundbreaking idea the physicist has overcome the diffraction resolution barrier in optical microscopy
ECHA publishes an updated list of pre-registered substances
NIST research highlights promise of AFM-IR for quantitative nanoscale chemical analysis.
Fritsch as Authorized Economic Operator (AEO-F) certified